Skip to content
2000
Volume 26, Issue 16
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Vaginal douching is a centuries-old practice which is still in use, especially among adolescents. “Probiotic douches” are the vaginal douches that are formulated with probiotics and are intended to restore or maintain the vaginal microbiome balance. Probiotic douches are a new type of feminine hygiene product that claims to promote a balanced vaginal microbiome and improve overall well-being. However, the evidence supporting the use of probiotics for vaginal health is limited because of the variability in probiotic strains and dosages studied, and the lack of more comprehensive, long-term clinical trials. Most of the existing scientific literature on probiotics focuses on oral probiotic supplements and vaginal probiotic suppositories. Some potential benefits of probiotic douches include restoring a balanced vaginal microbiota, preventing, or managing infections, supporting local immune function, reducing odor and discharge, and enhancing overall vaginal comfort. However, it is important to note that these benefits have not been definitively proven and remain a subject of ongoing research. There are also potential risks associated with their use including disruption of the natural vaginal ecosystem by introducing foreign substances, risk of infection, and stability issues with the formulation that may lead to negative consequences. This review attempts to comprehend the critical need for robust scientific research to guide the safe and effective incorporation of probiotic douches into modern feminine hygiene practices, revolutionizing women's health, and well-being.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010322564240929204907
2024-10-09
2025-12-13

  • From This Site

    /content/journals/cpb/10.2174/0113892010322564240929204907
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AralS.O. MosherW.D. CatesW.Jr Vaginal douching among women of reproductive age in the United States: 1988.Am. J. Public Health199282221021410.2105/AJPH.82.2.2101739149
     [Google Scholar]
  2. MonifG.R.G. The great douching debate: To douche, or not to douche.Obstet. Gynecol.199994463063110.1097/00006250‑199910000‑0002710511372
     [Google Scholar]
  3. AngerJ. LeeU. AckermanA.L. ChouR. ChughtaiB. ClemensJ.Q. HicklingD. KapoorA. KentonK.S. KaufmanM.R. RondaninaM.A. StapletonA. StothersL. ChaiT.C. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline.J. Urol.2019202228228910.1097/JU.000000000000029631042112
     [Google Scholar]
  4. Puebla-BarraganS. ReidG. Probiotics in cosmetic and personal care products: Trends and challenges.Molecules2021265124910.3390/molecules2605124933652548
     [Google Scholar]
  5. MashatanN. HeidariR. AltafiM. AmiriA. OmmatiM.M. HashemzaeiM. Probiotics in vaginal health.Pathog. Dis.202381ftad01210.1093/femspd/ftad01237286796
     [Google Scholar]
  6. CribbyS TaylorM ReidG Vaginal microbiota and the use of probiotics.Interdiscip. Perspect. Infect. Dis.2008200825649010.1155/2008/256490
     [Google Scholar]
  7. LinY.P. ChenW.C. ChengC.M. ShenC.J. Vaginal pH value for clinical diagnosis and treatment of common vaginitis.Diagnostics20211111199610.3390/diagnostics1111199634829343
     [Google Scholar]
  8. CheeW.J.Y. ChewS.Y. ThanL.T.L. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health.Microb. Cell Fact.202019120310.1186/s12934‑020‑01464‑433160356
     [Google Scholar]
  9. KimJ.M. ParkY.J. Probiotics in the prevention and treatment of postmenopausal vaginal infections.J. Menopausal Med.201723313914510.6118/jmm.2017.23.3.13929354612
     [Google Scholar]
  10. FashemiB. DelaneyM.L. OnderdonkA.B. FichorovaR.N. Effects of feminine hygiene products on the vaginal mucosal biome.Microb. Ecol. Health Dis.20132411970324009546
     [Google Scholar]
  11. ZuzeloP.R. Holistic care for women includes addressing vaginal health.Holist. Nurs. Pract.201731213713910.1097/HNP.000000000000020228181980
     [Google Scholar]
  12. redondo-LopezV. CookR.L. SobelJ.D. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora.Clin. Infect. Dis.199012585687210.1093/clinids/12.5.8562237129
     [Google Scholar]
  13. KoningsW. KokJ. KuipersO.P. PoolmanB. Lactic acid bacteria: The bugs of the new millennium.Curr. Opin. Microbiol.20003327628210.1016/S1369‑5274(00)00089‑810851157
     [Google Scholar]
  14. ReidG. Probiotic Lactobacilli for urogenital health in women.J. Clin. Gastroenterol.200842Suppl. 3S234S23610.1097/MCG.0b013e31817f129818685506
     [Google Scholar]
  15. ReidG. CharbonneauD. ErbJ. KochanowskiB. BeuermanD. PoehnerR. BruceA.W. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: Randomized, placebo-controlled trial in 64 healthy women.FEMS Immunol. Med. Microbiol.200335213113410.1016/S0928‑8244(02)00465‑012628548
     [Google Scholar]
  16. RavelJ. GajerP. AbdoZ. SchneiderG.M. KoenigS.S.K. McCulleS.L. KarlebachS. GorleR. RussellJ. TacketC.O. BrotmanR.M. DavisC.C. AultK. PeraltaL. ForneyL.J. Vaginal microbiome of reproductive-age women.Proc. Natl. Acad. Sci. USA2011108Suppl 1Suppl. 14680468710.1073/pnas.100261110720534435
     [Google Scholar]
  17. MortonA.M. Freedom from worry: Douching as a case study for historical archaeological approaches to women’s health.University of Idaho2013
     [Google Scholar]
  18. AbmaJ.C. ChandraA. MosherW.D. PetersonL.S. PiccininoL.J. Fertility, family planning, and women's health: New data from the 1995 national survey of family growth.Vital Health Stat 231997191114
     [Google Scholar]
  19. Key statistics from the National Survey of Family Growth—I listing.Available from: https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm
  20. MerchantJ.S. OhM.K. KlermanL.V. Douching.Arch. Pediatr. Adolesc. Med.1999153883483710.1001/archpedi.153.8.83410437756
     [Google Scholar]
  21. CottrellB.H. An updated review of of evidence to discourage douching.MCN Am. J. Matern. Child Nurs.201035210210710.1097/NMC.0b013e3181cae9da20215951
     [Google Scholar]
  22. FochB.J. McDanielN.D. ChackoM.R. Racial differences in vaginal douching knowledge, attitude, and practices among sexually active adolescents.J. Pediatr. Adolesc. Gynecol.2001141293310.1016/S1083‑3188(00)00080‑211358704
     [Google Scholar]
  23. VermundS.H. SarrM. MurphyD.A. LevinL. AbdalianS.E. MaY. Crowley-NowickP.A. WilsonC.M. Adolescent Medicine HIV/AIDS Research Network Douching practices among HIV infected and uninfected adolescents in the United States.J. Adolesc. Health2001293Suppl.808610.1016/S1054‑139X(01)00284‑111530307
     [Google Scholar]
  24. OhM.K. MerchantJ.S. BrownP. Douching behavior in high-risk adolescents. What do they use, when and why do they douche?J. Pediatr. Adolesc. Gynecol.2002152838810.1016/S1083‑3188(01)00148‑612057529
     [Google Scholar]
  25. BlytheM.J. FortenberryJ.D. OrrD.P. Douching behaviors reported by adolescent and young adult women at high risk for sexually transmitted infections.J. Pediatr. Adolesc. Gynecol.20031629510010.1016/S1083‑3188(03)00027‑512742144
     [Google Scholar]
  26. OhM. SimpsonT. VazinT. SpiveyC. BrownP. DaviesS. ScissumgunnK. Vaginal douching and reproductive health protection practices of university students.J. Adolesc. Health200434214710.1016/S1054‑139X(03)00457‑9
     [Google Scholar]
  27. GuptaS. KakkarV. BhushanI. Crosstalk between vaginal microbiome and female health: A review.Microb. Pathog.201913610369610.1016/j.micpath.2019.10369631449855
     [Google Scholar]
  28. BoltonM. van der StratenA. CohenC.R. Probiotics: Potential to prevent HIV and sexually transmitted infections in women.Sex. Transm. Dis.200835321422510.1097/OLQ.0b013e31815b017a18490864
     [Google Scholar]
  29. BertiniM SerdarogluS KutlubayZ Bacterial vaginosis and sexually transmitted diseases: Relationship and management. Fundamentals of Sexually Transmitted Infections. InTech201710.5772/intechopen.69258
     [Google Scholar]
  30. SchwebkeJ.R. Role of vaginal flora as a barrier to HIV acquisition.Curr. Infect. Dis. Rep.20013215215510.1007/s11908‑996‑0040‑611286657
     [Google Scholar]
  31. FarageMA MillerKW SobelJD Dynamics of the vaginal ecosystem—hormonal influences.Infect. Dis. Res. Treat.20103S3903
     [Google Scholar]
  32. ReidG. BockingA. The potential for probiotics to prevent bacterial vaginosis and preterm labor.Am. J. Obstet. Gynecol.200318941202120810.1067/S0002‑9378(03)00495‑214586379
     [Google Scholar]
  33. DoverS.E. AroutchevaA.A. FaroS. ChikindasM.L. Natural antimicrobials and their role in vaginal health: A short review.Int. J. Probiotics Prebiotics20083421923020657710
     [Google Scholar]
  34. RampersaudR. RandisT.M. RatnerA.J. Microbiota of the upper and lower genital tract.Seminars in Fetal and Neonatal Medicine.Elsevier2012
     [Google Scholar]
  35. GuptaV. GargR. Probiotics.Indian J. Med. Microbiol.200927320220910.4103/0255‑0857.5320119584499
     [Google Scholar]
  36. AnukamK. OsazuwaE. AhonkhaiI. NgwuM. OsemeneG. BruceA.W. ReidG. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, double-blind, placebo controlled trial.Microbes Infect.2006861450145410.1016/j.micinf.2006.01.00316697231
     [Google Scholar]
  37. BeerepootM.A.J. ter RietG. NysS. van der WalW.M. de BorgieC.A. de ReijkeT.M. PrinsJ.M. KoeijersJ. VerbonA. StobberinghE. GeerlingsS.E. Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women.Arch. Intern. Med.2012172970471210.1001/archinternmed.2012.77722782199
     [Google Scholar]
  38. DondersG.G.G. VereeckenA. BosmansE. DekeersmaeckerA. SalembierG. SpitzB. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: Aerobic vaginitis.BJOG20021091344310.1111/j.1471‑0528.2002.00432.x11845812
     [Google Scholar]
  39. JahicM. MulavdicM. NurkicJ. JahicE. NurkicM. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis.Med. Arh.201367642843010.5455/medarh.2013.67.428‑43025568514
     [Google Scholar]
  40. PeeblesK. VellozaJ. BalkusJ.E. McClellandR.S. BarnabasR.V. High global burden and costs of bacterial vaginosis: A systematic review and meta-analysis.Sex. Transm. Dis.201946530431110.1097/OLQ.000000000000097230624309
     [Google Scholar]
  41. CoudrayM.S. MadhivananP. Bacterial vaginosis—A brief synopsis of the literature.Eur. J. Obstet. Gynecol. Reprod. Biol.202024514314810.1016/j.ejogrb.2019.12.03531901667
     [Google Scholar]
  42. VodstrcilL.A. MuznyC.A. PlummerE.L. SobelJ.D. BradshawC.S. Bacterial vaginosis: Drivers of recurrence and challenges and opportunities in partner treatment.BMC Med.202119119410.1186/s12916‑021‑02077‑334470644
     [Google Scholar]
  43. MakanjuolaO. BongominF. FayemiwoS. An update on the roles of non-albicans Candida species in vulvovaginitis.J. Fungi20184412110.3390/jof404012130384449
     [Google Scholar]
  44. SobelJ.D. 53 - Vaginitis, vulvitis, cervicitis and cutaneous vulval lesions.Infectious Diseases.4th ed CohenJ. PowderlyW.G. OpalS.M. Elsevier201748391.e110.1016/B978‑0‑7020‑6285‑8.00053‑8
     [Google Scholar]
  45. SzybalaM.P. SzybalaC. 224 - Vaginitis, Vulvovaginitis, and Vulvodynia.Textbook of Natural Medicine.5th ed PizzornoJ.E. MurrayM.T. St. Louis, MOChurchill Livingstone202018409.e410.1016/B978‑0‑323‑43044‑9.00224‑7
     [Google Scholar]
  46. RaoV.L. MahmoodT. Vaginal discharge.Obstetrics, Gynaecol. Reprod. Med.2020301111810.1016/j.ogrm.2019.10.004
     [Google Scholar]
  47. TineRC SyllaK KaR DiaL SowD LeloS A study of Trichomonas vaginalis infection and correlates in women with vaginal discharge referred at Fann Teaching Hospital in Senegal.J. Parasitol. Res.20192019
     [Google Scholar]
  48. SilverB.J. GuyR.J. KaldorJ.M. JamilM.S. RumboldA.R. Trichomonas vaginalis as a cause of perinatal morbidity: A systematic review and meta-analysis.Sex. Transm. Dis.201441636937610.1097/OLQ.000000000000013424825333
     [Google Scholar]
  49. DaskalakisG. PsarrisA. KoutrasA. FasoulakisZ. ProkopakisI. VarthalitiA. KarasmaniC. NtounisT. DomaliE. TheodoraM. AntsaklisP. PappaK.I. PapapanagiotouA. Maternal infection and preterm birth: From molecular basis to clinical implications.Children202310590710.3390/children1005090737238455
     [Google Scholar]
  50. CotchM.F. PastorekJ.G.II NugentR.P. HillierS.L. GibbsR.S. MartinD.H. EschenbachD.A. EdelmanR. CareyC.J. ReganJ.A. KrohnM.A. KlebanoffM.A. RaoV.A. RhoadsG.G. The Vaginal Infections and Prematurity Study Group Trichomonas vaginalis associated with low birth weight and preterm delivery.Sex. Transm. Dis.199724635336010.1097/00007435‑199707000‑000089243743
     [Google Scholar]
  51. ChiuS.F. HuangP.J. ChengW.H. HuangC.Y. ChuL.J. LeeC.C. LinH.C. ChenL.C. LinW.N. TsaoC.H. TangP. YehY.M. HuangK.Y. Vaginal microbiota of the sexually transmitted infections caused by Chlamydia trachomatis and Trichomonas vaginalis in women with vaginitis in Taiwan.Microorganisms202199186410.3390/microorganisms909186434576759
     [Google Scholar]
  52. Van GerwenO.T. MuznyC.A. MarrazzoJ.M. Sexually transmitted infections and female reproductive health.Nat. Microbiol.2022781116112610.1038/s41564‑022‑01177‑x35918418
     [Google Scholar]
  53. ZhangZ.F. GrahamS. YuS.Z. MarshallJ. ZieleznyM. ChenY.X. SunM. TangS.L. LiaoC.S. XuJ.L. YangX-Z. Trichomonas vaginalis and cervical cancer.Ann. Epidemiol.19955432533210.1016/1047‑2797(94)00101‑X8520717
     [Google Scholar]
  54. KudelaE. LiskovaA. SamecM. KoklesovaL. HolubekovaV. RokosT. KozubikE. PribulovaT. ZhaiK. BusselbergD. KubatkaP. BiringerK. The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.EPMA J.202112219922010.1007/s13167‑021‑00244‑334194585
     [Google Scholar]
  55. CudmoreS.L. GarberG.E. Prevention or treatment: The benefits of Trichomonas vaginalis vaccine.J. Infect. Public Health201032475310.1016/j.jiph.2010.01.00320701891
     [Google Scholar]
  56. MirzadehM. OlfatifarM. EslahiA.V. AbdoliA. HoushmandE. MajidianiH. JohkoolM.G. AskariS. HashemipourS. BadriM. Global prevalence of Trichomonas vaginalis among female sex workers: A systematic review and meta-analysis.Parasitol. Res.202112072311232210.1007/s00436‑021‑07216‑634170387
     [Google Scholar]
  57. PalmaE. RecineN. DomeniciL. GiorginiM. PierangeliA. PaniciP.B. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: A promising solution against HPV-infection.BMC Infect. Dis.20181811310.1186/s12879‑017‑2938‑z29304768
     [Google Scholar]
  58. BorgesS. SilvaJ. TeixeiraP. The role of lactobacilli and probiotics in maintaining vaginal health.Arch. Gynecol. Obstet.2014289347948910.1007/s00404‑013‑3064‑924170161
     [Google Scholar]
  59. StrusM. KucharskaA. KuklaG. Brzychczy-WłochM. MareszK. HeczkoP.B. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida.Infect. Dis. Obstet. Gynecol.2005132697510.1080/1064744040002813616011996
     [Google Scholar]
  60. O’HanlonD.E. MoenchT.R. ConeR.A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide.BMC Infect. Dis.201111120010.1186/1471‑2334‑11‑20021771337
     [Google Scholar]
  61. CharlierC. CretenetM. EvenS. Le LoirY. Interactions between Staphylococcus aureus and lactic acid bacteria: An old story with new perspectives.Int. J. Food Microbiol.20091311303910.1016/j.ijfoodmicro.2008.06.03218687499
     [Google Scholar]
  62. ReidG. KimS.O. KöhlerG.A. Selecting, testing and understanding probiotic microorganisms.FEMS Immunol. Med. Microbiol.200646214915710.1111/j.1574‑695X.2005.00026.x16487295
     [Google Scholar]
  63. HickeyR.J. ZhouX. PiersonJ.D. RavelJ. ForneyL.J. Understanding vaginal microbiome complexity from an ecological perspective.Transl. Res.2012160426728210.1016/j.trsl.2012.02.00822683415
     [Google Scholar]
  64. ContiC. MalacrinoC. MastromarinoP. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli.J. Physiol. Pharmacol.200960Suppl. 6192620224147
     [Google Scholar]
  65. NardisC. MoscaL. MastromarinoP. Vaginal microbiota and viral sexually transmitted diseases.Ann. Ig.201325544345624048183
     [Google Scholar]
  66. LinQ. LimJ.Y.C. XueK. YewP.Y.M. OwhC. CheeP.L. LohX.J. Sanitizing agents for virus inactivation and disinfection.VIEW202012e1610.1002/viw2.1634766164
     [Google Scholar]
  67. KimY KimC ChoM NaJ SongT OhJ. Hydrogen peroxide-producing Lactobacilli in the vaginal flora of pregnant women with preterm labor with intact membranes.Int. J. Gynecol. Obstet.20069312227
     [Google Scholar]
  68. MuenchD.F. KuchD.J. WuH. BegumA.A. VeitS.J. PelletierM.E. Soler-GarcíaÁ.A. JerseA.E. Hydrogen peroxide-producing lactobacilli inhibit gonococci in vitro but not during experimental genital tract infection.J. Infect. Dis.200919991369137810.1086/59739019301977
     [Google Scholar]
  69. GillorO. NigroL. RileyM. Genetically engineered bacteriocins and their potential as the next generation of antimicrobials.Curr. Pharm. Des.20051181067107510.2174/138161205338166615777256
     [Google Scholar]
  70. CotterP.D. HillC. RossR.P. Bacteriocins: developing innate immunity for food.Nat. Rev. Microbiol.200531077778810.1038/nrmicro127316205711
     [Google Scholar]
  71. RileyM.A. WertzJ.E. Bacteriocins: Evolution, ecology, and application.Annu. Rev. Microbiol.200256111713710.1146/annurev.micro.56.012302.16102412142491
     [Google Scholar]
  72. ReaM.C. DobsonA. O’SullivanO. CrispieF. FouhyF. CotterP.D. ShanahanF. KielyB. HillC. RossR.P. Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.Proc. Natl. Acad. Sci. USA2011108Suppl 1Suppl. 14639464410.1073/pnas.100122410720616009
     [Google Scholar]
  73. CorsettiA. SettanniL. Lactobacilli in sourdough fermentation.Food Res. Int.200740553955810.1016/j.foodres.2006.11.001
     [Google Scholar]
  74. DriderD. RebuffatS. Prokaryotic antimicrobial peptides: From genes to applications.Springer Science & Business Media201110.1007/978‑1‑4419‑7692‑5
     [Google Scholar]
  75. GolowczycM.A. GugliadaM.J. HollmannA. DelfedericoL. GarroteG.L. AbrahamA.G. SemorileL. De AntoniG. Characterization of homofermentative lactobacilli isolated from kefir grains: Potential use as probiotic.J. Dairy Res.200875221121710.1017/S002202990800311718474139
     [Google Scholar]
  76. OcañaV.S. Pesce de Ruiz HolgadoA.A. Nader-MacíasM.E. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain.Appl. Environ. Microbiol.199965125631563510.1128/AEM.65.12.5631‑5635.199910584033
     [Google Scholar]
  77. AroutchevaA. GaritiD. SimonM. ShottS. FaroJ. SimoesJ.A. GurguisA. FaroS. Defense factors of vaginal lactobacilli.Am. J. Obstet. Gynecol.2001185237537910.1067/mob.2001.11586711518895
     [Google Scholar]
  78. PascualL.M. DanieleM.B. GiordanoW. PájaroM.C. BarberisI.L. Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23.Curr. Microbiol.200856439740210.1007/s00284‑007‑9094‑418172715
     [Google Scholar]
  79. Vera PingitoreE. HébertE.M. Nader-MacíasM.E. SesmaF. Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina.Res. Microbiol.2009160640140810.1016/j.resmic.2009.06.00919591924
     [Google Scholar]
  80. DezwaanD.C. MequioM.J. LittellJ.S. AllenJ.P. RossbachS. PybusV. Purification and characterization of enterocin 62-6, a two-peptide bacteriocin produced by a vaginal strain of Enterococcus faecium: Potential significance in bacterial vaginosis.Microb. Ecol. Health Dis.200719424125019578555
     [Google Scholar]
  81. GodhaK. TuckerK.M. BiehlC. ArcherD.F. MirkinS. Human vaginal pH and microbiota: An update.Gynecol. Endocrinol.201834645145510.1080/09513590.2017.140775329271266
     [Google Scholar]
  82. LinharesIM SummersPR LarsenB GiraldoPC WitkinSS Contemporary perspectives on vaginal pH and lactobacilli.Am. J. Obstet. Gynecol.2011204212010.1016/j.ajog.2010.07.010
     [Google Scholar]
  83. BoskeyE.R. TelschK.M. WhaleyK.J. MoenchT.R. ConeR.A. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.Infect. Immun.199967105170517510.1128/IAI.67.10.5170‑5175.199910496892
     [Google Scholar]
  84. VaneechoutteM. The human vaginal microbial community.Res. Microbiol.20171689-1081182510.1016/j.resmic.2017.08.00128851670
     [Google Scholar]
  85. TachedjianG. AldunateM. BradshawC.S. ConeR.A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health.Res. Microbiol.20171689-1078279210.1016/j.resmic.2017.04.00128435139
     [Google Scholar]
  86. CoudeyrasS JugieG VermerieM ForestierC Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens.Infect. Dis. Obstet. Gynecol.20082008
     [Google Scholar]
  87. KudelkaM.R. StowellS.R. CummingsR.D. NeishA.S. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.Nat. Rev. Gastroenterol. Hepatol.2020171059761710.1038/s41575‑020‑0331‑732710014
     [Google Scholar]
  88. MoranA.P. GuptaA. JoshiL. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract.Gut201160101412142510.1136/gut.2010.21270421228430
     [Google Scholar]
  89. BorisS. SuárezJ.E. VázquezF. BarbésC. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens.Infect. Immun.19986651985198910.1128/IAI.66.5.1985‑1989.19989573080
     [Google Scholar]
  90. PascualL.M. DanieleM.B. RuizF. GiordanoW. PájaroC. BarberisL. Lactobacillus rhamnosus L60, a potential probiotic isolated from the human vagina.J. Gen. Appl. Microbiol.200854314114810.2323/jgam.54.14118654035
     [Google Scholar]
  91. TurroniF. VenturaM. ButtóL.F. DurantiS. O’TooleP.W. MotherwayM.O.C. van SinderenD. Molecular dialogue between the human gut microbiota and the host: A Lactobacillus and Bifidobacterium perspective.Cell. Mol. Life Sci.201471218320310.1007/s00018‑013‑1318‑023516017
     [Google Scholar]
  92. RussoR. KaradjaE. De SetaF. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: A double blind, placebo controlled, randomised clinical trial.Benef. Microbes2019101192610.3920/BM2018.007530525953
     [Google Scholar]
  93. MastromarinoP. MacchiaS. MeggioriniL. TrinchieriV. MoscaL. PerluigiM. MidullaC. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.Clin. Microbiol. Infect.2009151677410.1111/j.1469‑0691.2008.02112.x19046169
     [Google Scholar]
  94. MeiZ. LiD. The role of probiotics in vaginal health.Front. Cell. Infect. Microbiol.20221296386810.3389/fcimb.2022.96386835967876
     [Google Scholar]
  95. MartinoJ.L. VermundS.H. Vaginal douching: Evidence for risks or benefits to women’s health.Epidemiol. Rev.200224210912410.1093/epirev/mxf00412762087
     [Google Scholar]
  96. HeshamH. MitchellA.J. BergeratA. HungK. MitchellC.M. Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses.Sci. Rep.20211112306910.1038/s41598‑021‑02426‑534845288
     [Google Scholar]
  97. SwansonK.S. GibsonG.R. HutkinsR. ReimerR.A. ReidG. VerbekeK. ScottK.P. HolscherH.D. AzadM.B. DelzenneN.M. SandersM.E. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.Nat. Rev. Gastroenterol. Hepatol.2020171168770110.1038/s41575‑020‑0344‑232826966
     [Google Scholar]
  98. DiClementeR.J. YoungA.M. PainterJ.L. WingoodG.M. RoseE. SalesJ.M. Prevalence and correlates of recent vaginal douching among African American adolescent females.J. Pediatr. Adolesc. Gynecol.2012251485310.1016/j.jpag.2011.07.01722051790
     [Google Scholar]
  99. JayamuraliD. SaminathanG. VarierK.M. AcharyaP.S. ManoharanN. ParasuramanR. Revealing the hidden heights of microbial metabolites on reproductive physiology.Recent Advances and Future Perspectives of Microbial MetabolitesAcademic Press202321724810.1016/B978‑0‑323‑90113‑0.00004‑3
     [Google Scholar]
  100. MinelliE.B. BeniniA. Relationship between number of bacteria and their probiotic effects.Microb. Ecol. Health Dis.2008204180183
     [Google Scholar]
  101. HansonL. VandeVusseL. JerméM. AbadC.L. SafdarN. Probiotics for treatment and prevention of urogenital infections in women: A systematic review.J. Midwifery Womens Health201661333935510.1111/jmwh.1247227218592
     [Google Scholar]
  102. MisraD.P. TrabertB. Atherly-TrimS. Variation and predictors of vaginal douching behavior.Womens Health Issues200616527528210.1016/j.whi.2006.03.00517055380
     [Google Scholar]
  103. BrotmanR.M. KlebanoffM.A. NanselT.R. AndrewsW.W. SchwebkeJ.R. ZhangJ. YuK.F. ZenilmanJ.M. ScharfsteinD.O. A longitudinal study of vaginal douching and bacterial vaginosis--A marginal structural modeling analysis.Am. J. Epidemiol.2008168218819610.1093/aje/kwn10318503038
     [Google Scholar]
  104. GonzalezN.L. O’BrienK.M. D’AloisioA.A. SandlerD.P. WeinbergC.R. Douching, talc use, and risk of ovarian cancer.Epidemiology201627679780210.1097/EDE.000000000000052827327020
     [Google Scholar]
  105. BrotmanRM GhanemKG KlebanoffMA TahaTE ScharfsteinDO ZenilmanJM The effect of vaginal douching cessation on bacterial vaginosis: A pilot study.Am. J. Obstet. Gynecol.2008198662810.1016/j.ajog.2007.11.043
     [Google Scholar]
  106. HengL.S. YatsuyaH. MoritaS. SakamotoJ. Vaginal douching in Cambodian women: Its prevalence and association with vaginal candidiasis.J. Epidemiol.2010201707610.2188/jea.JE2008104620009371
     [Google Scholar]
  107. OcaktanM.E. BaranE. AkdurR. Evaluation of habitual behavior related to genital hygiene in women living in a health care center area.Saudi Med. J.201031111251125621063658
     [Google Scholar]
  108. NessR.B. SoperD. HolleyR.L. PeipertJ. RandallH. SweetR.L. SondheimerS.J. HendrixS.L. HillierS.L. AmorteguiA. TruccoG. BassD.C. PID Evaluation and Clinical Health (PEACH) Study Investigators Douching and Endometritis.Sex. Transm. Dis.200128424024510.1097/00007435‑200104000‑0001011318257
     [Google Scholar]
  109. ZengX ZhangY ZhangT XueY XuH AnR Risk factors of vulvovaginal candidiasis among women of reproductive age in Xi’an: A cross-sectional study.Biomed. Res. Int.2018201810.1155/2018/9703754
     [Google Scholar]
  110. PinesH.A. SempleS.J. StrathdeeS.A. HendrixC.W. Harvey-VeraA. GorbachP.M. Magis-RodríguezC. MartinezG. PattersonT.L. Vaginal washing and lubrication among female sex workers in the Mexico-US border region: Implications for the development of vaginal PrEP for HIV prevention.BMC Public Health2018181100910.1186/s12889‑018‑5946‑z30107833
     [Google Scholar]
  111. von GlehnM.P. SidonL. MachadoE. Gynecological complaints and their associated factors among women in a family health-care clinic.J. Family Med. Prim. Care201761889210.4103/2249‑4863.21498229026756
     [Google Scholar]
  112. LuoL. XuJ.J. WangG.X. DingG.W. WangN. WangH.B. Vaginal douching and association with sexually transmitted infections among female sex workers in a prefecture of Yunnan Province, China.Int. J. STD AIDS201627756056710.1177/095646241558904426016725
     [Google Scholar]
  113. EsberA. RaoN. NorrisA. Carr ReeseP. KandodoJ. NampandeniP. JumbeE. Norris TurnerA. Intravaginal practices and prevalence of sexual and reproductive tract infections among women in rural Malawi.Sex. Transm. Dis.2016431275075510.1097/OLQ.000000000000053127835627
     [Google Scholar]
  114. CarterM. GalloM. AndersonC. SneadM.C. WienerJ. BaileyA. CostenbaderE. Legardy-WilliamsJ. Hylton-KongT. Intravaginal cleansing among women attending a sexually transmitted infection clinic in Kingston, Jamaica.West Indian Med. J.2013621566124171329
     [Google Scholar]
  115. MaseseL. McClellandR.S. GitauR. WanjeG. ShafiJ. KashongaF. Ndinya-AcholaJ.O. LesterR. RichardsonB.A. KurthA. A pilot study of the feasibility of a vaginal washing cessation intervention among Kenyan female sex workers.Sex. Transm. Infect.201389321722210.1136/sextrans‑2012‑05056423002190
     [Google Scholar]
  116. GüzelA.I. KuyumcuoğluU. CelikY. Vaginal douching practice and related symptoms in a rural area of Turkey.Arch. Gynecol. Obstet.201128451153115610.1007/s00404‑010‑1805‑621153831
     [Google Scholar]
  117. HassanS. ChatwaniA. BrovenderH. ZaneR. ValaorasT. SobelJ.D. Douching for perceived vaginal odor with no infectious cause of vaginitis: A randomized controlled trial.J. Low. Genit. Tract Dis.201115212813310.1097/LGT.0b013e3181fb427021263351
     [Google Scholar]
  118. ArslantasD. KarabagliH. KocF. Vaginal douching practice in Eskisehir in Turkey.J. Public Health Epidemiol.201029245250
     [Google Scholar]
  119. MairigaA.G. KullimaA.A. KawuwaM.B. Social and health reasons for lime juice vaginal douching among female sex workers in Borno State, Nigeria.Afr. J. Prim. Health Care Fam. Med.2010211410.4102/phcfm.v2i1.125
     [Google Scholar]
  120. McKeeM.D. BaqueroM. AndersonM.R. AlvarezA. KaraszA. Vaginal douching among Latinas: Practices and meaning.Matern. Child Health J.20091319810610.1007/s10995‑008‑0327‑318297379
     [Google Scholar]
  121. HacıalioğluN. NazikE. KılıçM. A descriptive study of douching practices in Turkish women.Int. J. Nurs. Pract.2009152576410.1111/j.1440‑172X.2009.01735.x19335521
     [Google Scholar]
  122. ChenT LinF HouY Application of lactobacillus crispatus in preparation of medicine for treating intrauterine adhesion.Patent CN115607578A,2023
  123. SunJ WangX Probiotic compound preparation and application thereof in regulation of vaginal flora and resistance to HPV.Patent CN112501051A,2021
  124. BradshawC.S. SobelJ.D. Current treatment of bacterial vaginosis—limitations and need for innovation.J. Infect. Dis.2016214Suppl 1S14S2010.1093/infdis/jiw15927449869
     [Google Scholar]
  125. Krebs-BenschA Vaginal probiotic products and related processes.Patent US10258567B1,2019
  126. KoenigDW SchollNT TopolkaraevVa HeuvelALV Protein stabilized probiotics and personal care products.Patent US2014065210A1,2014
  127. KaurIP SharmaG Probiotic formulation and uses thereof.Patent WO2019180748A1,2019
  128. CastroIE BorquezYR GonzalesRM AeschlimannAV Pharmaceutical composition including viable probiotic strains of lactobacillus spp. used for the prevention and recovery of individuals with urinary tract infections and immunocompromised individuals.Patent WO2011000124A1,2011
  129. ChenollCME CasinosRB SilvaAA RamonVD GenovesMS Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis.Patent US10588926B2,2020
  130. SamuelssonC WeinerJA KvantaE Lactic acid producing bacteria for use as probiotic organisms in the human vagina.Patent US2004253217A1,2004
  131. VolkmannP-H Vaginal care composition.Patent US2005095232A1,2005
  132. BykovVa DalinMV KuzMEN Lactobacterium-Containing Suppository for Treatment of Patient with Vagina Dysbacteriosis.Patent RU2150268C1,2000
  133. CavaliereVRM DeSC Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections.Patent EP0956858A1,1999
  134. SimpsonT. MerchantJ. GrimleyD.M. Kim OhM. Vaginal douching among adolescent and young women: More challenges than progress.J. Pediatr. Adolesc. Gynecol.200417424925510.1016/j.jpag.2004.05.00815288026
     [Google Scholar]
  135. HawesS.E. HillierS.L. BenedettiJ. StevensC.E. KoutskyL.A. Wølner-HanssenP. HolmesK.K. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections.J. Infect. Dis.199617451058106310.1093/infdis/174.5.10588896509
     [Google Scholar]
  136. NessR.B. HillierS.L. KipK.E. RichterH.E. SoperD.E. StammC.A. McGregorJ.A. BassD.C. RiceP. SweetR.L. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.Am. J. Epidemiol.2005161218619510.1093/aje/kwi02515632269
     [Google Scholar]
  137. Anstey WatkinsJ. RossJ.D.C. ThandiS. BrittainC. KaiJ. GriffithsF. Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.PLoS One20191411e022496410.1371/journal.pone.022496431730666
     [Google Scholar]
  138. Plaza-DiazJ. Ruiz-OjedaF.J. Gil-CamposM. GilA. Mechanisms of action of probiotics.Adv. Nutr.201910Suppl. 1S49S6610.1093/advances/nmy06330721959
     [Google Scholar]
  139. MendlingW. Vaginal Microbiota.Adv. Exp. Med. Biol.2016902839310.1007/978‑3‑319‑31248‑4_627161352
     [Google Scholar]
  140. MaD. ChenY. ChenT. Vaginal microbiota transplantation for the treatment of bacterial vaginosis: A conceptual analysis.FEMS Microbiol. Lett.20193664fnz02510.1093/femsle/fnz02530715301
     [Google Scholar]
  141. MikamoH. SatoY. HayasakiY. HuaY.X. TamayaT. Vaginal microflora in healthy women with Gardnerella vaginalis.J. Infect. Chemother.20006317317710.1007/s10156007001811810560
     [Google Scholar]
  142. BabuG. SingaraveluB.G. SrikumarR. ReddyS.V. KokanA. Comparative study on the vaginal flora and incidence of asymptomatic vaginosis among healthy women and in women with infertility problems of reproductive age.J. Clin. Diagn. Res.2017118DC18DC2210.7860/JCDR/2017/28296.1041728969122
     [Google Scholar]
  143. PetrovaM.I. van den BroekM. BalzariniJ. VanderleydenJ. LebeerS. Vaginal microbiota and its role in HIV transmission and infection.FEMS Microbiol. Rev.201337576279210.1111/1574‑6976.1202923789590
     [Google Scholar]
  144. PendharkarS. Skafte-HolmA. SimsekG. HaahrT. Lactobacilli and their probiotic effects in the vagina of reproductive age women.Microorganisms202311363610.3390/microorganisms1103063636985210
     [Google Scholar]
  145. AbbasiA. Aghebati-MalekiL. Homayouni-RadA. The promising biological role of postbiotics derived from probiotic Lactobacillus species in reproductive health.Crit. Rev. Food Sci. Nutr.202262328829884110.1080/10408398.2021.193570134152234
     [Google Scholar]
  146. AbbasiA. RadA.H. GhasempourZ. SabahiS. KafilH.S. HasannezhadP. Rahbar SaadatY. ShahbaziN. The biological activities of postbiotics in gastrointestinal disorders.Crit. Rev. Food Sci. Nutr.202262225983600410.1080/10408398.2021.189506133715539
     [Google Scholar]
  147. Homayouni RadA. Aghebati MalekiL. Samadi KafilH. Fathi ZavoshtiH. AbbasiA. Postbiotics as promising tools for cancer adjuvant therapy.Adv. Pharm. Bull.20201111510.34172/apb.2021.00733747846
     [Google Scholar]
/content/journals/cpb/10.2174/0113892010322564240929204907
Loading
Bridging the GAP: Probiotic Douches Redefining the Feminine Hygiene
Current Pharmaceutical Biotechnology 26, 2503 (2025); https://doi.org/10.2174/0113892010322564240929204907
/content/journals/cpb/10.2174/0113892010322564240929204907
/content/journals/cpb/10.2174/0113892010322564240929204907
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): clinical trials; douches; feminine hygiene practices; patents; probiotics; Vaginal health

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test